Systems biology of Alzheimer's disease

How diverse molecular changes result in memory impairment in AD

G. Juhász, István Földi, B. Penke

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

Alzheimer's disease (AD) is a protein misfolding-based rapid cognitive impairment in the aging brain. Because of its very widespread molecular background, AD has been approached using genomic and proteomic methods and has accumulated a large body of data during the last 15 years. In this review, we summarize the systems biology data on AD and pay particular attention to the proteomic changes in AD. Applying a systems biology model of the synapse, we attempt to integrate protein changes and provide an explanation of why seemingly diverse molecular changes result in memory impairment. We also summarize the present state of cerebrospinal fluid (CSF) and blood biomarker studies for the diagnosis of AD as well as the results of proteomic studies in tissue cultures and animal models. Finally, we give a systems biology model of AD explaining how AD can develop in an individual manner in each particular subject but always results in a rapidly developing dementia and memory impairment.

Original languageEnglish
Pages (from-to)739-750
Number of pages12
JournalNeurochemistry International
Volume58
Issue number7
DOIs
Publication statusPublished - Jun 2011

Fingerprint

Systems Biology
Alzheimer Disease
Proteomics
Synapses
Cerebrospinal Fluid
Dementia
Proteins
Animal Models
Biomarkers
Brain

Keywords

  • β-Amyloid
  • Alzheimer's disease
  • Biomarkers
  • Proteomics
  • Synapse
  • Systems biology

ASJC Scopus subject areas

  • Cellular and Molecular Neuroscience
  • Cell Biology

Cite this

Systems biology of Alzheimer's disease : How diverse molecular changes result in memory impairment in AD. / Juhász, G.; Földi, István; Penke, B.

In: Neurochemistry International, Vol. 58, No. 7, 06.2011, p. 739-750.

Research output: Contribution to journalArticle

@article{0a3bc0cb1109474381722c8fcffbcd0e,
title = "Systems biology of Alzheimer's disease: How diverse molecular changes result in memory impairment in AD",
abstract = "Alzheimer's disease (AD) is a protein misfolding-based rapid cognitive impairment in the aging brain. Because of its very widespread molecular background, AD has been approached using genomic and proteomic methods and has accumulated a large body of data during the last 15 years. In this review, we summarize the systems biology data on AD and pay particular attention to the proteomic changes in AD. Applying a systems biology model of the synapse, we attempt to integrate protein changes and provide an explanation of why seemingly diverse molecular changes result in memory impairment. We also summarize the present state of cerebrospinal fluid (CSF) and blood biomarker studies for the diagnosis of AD as well as the results of proteomic studies in tissue cultures and animal models. Finally, we give a systems biology model of AD explaining how AD can develop in an individual manner in each particular subject but always results in a rapidly developing dementia and memory impairment.",
keywords = "β-Amyloid, Alzheimer's disease, Biomarkers, Proteomics, Synapse, Systems biology",
author = "G. Juh{\'a}sz and Istv{\'a}n F{\"o}ldi and B. Penke",
year = "2011",
month = "6",
doi = "10.1016/j.neuint.2011.02.008",
language = "English",
volume = "58",
pages = "739--750",
journal = "Neurochemistry International",
issn = "0197-0186",
publisher = "Elsevier Limited",
number = "7",

}

TY - JOUR

T1 - Systems biology of Alzheimer's disease

T2 - How diverse molecular changes result in memory impairment in AD

AU - Juhász, G.

AU - Földi, István

AU - Penke, B.

PY - 2011/6

Y1 - 2011/6

N2 - Alzheimer's disease (AD) is a protein misfolding-based rapid cognitive impairment in the aging brain. Because of its very widespread molecular background, AD has been approached using genomic and proteomic methods and has accumulated a large body of data during the last 15 years. In this review, we summarize the systems biology data on AD and pay particular attention to the proteomic changes in AD. Applying a systems biology model of the synapse, we attempt to integrate protein changes and provide an explanation of why seemingly diverse molecular changes result in memory impairment. We also summarize the present state of cerebrospinal fluid (CSF) and blood biomarker studies for the diagnosis of AD as well as the results of proteomic studies in tissue cultures and animal models. Finally, we give a systems biology model of AD explaining how AD can develop in an individual manner in each particular subject but always results in a rapidly developing dementia and memory impairment.

AB - Alzheimer's disease (AD) is a protein misfolding-based rapid cognitive impairment in the aging brain. Because of its very widespread molecular background, AD has been approached using genomic and proteomic methods and has accumulated a large body of data during the last 15 years. In this review, we summarize the systems biology data on AD and pay particular attention to the proteomic changes in AD. Applying a systems biology model of the synapse, we attempt to integrate protein changes and provide an explanation of why seemingly diverse molecular changes result in memory impairment. We also summarize the present state of cerebrospinal fluid (CSF) and blood biomarker studies for the diagnosis of AD as well as the results of proteomic studies in tissue cultures and animal models. Finally, we give a systems biology model of AD explaining how AD can develop in an individual manner in each particular subject but always results in a rapidly developing dementia and memory impairment.

KW - β-Amyloid

KW - Alzheimer's disease

KW - Biomarkers

KW - Proteomics

KW - Synapse

KW - Systems biology

UR - http://www.scopus.com/inward/record.url?scp=79955663597&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79955663597&partnerID=8YFLogxK

U2 - 10.1016/j.neuint.2011.02.008

DO - 10.1016/j.neuint.2011.02.008

M3 - Article

VL - 58

SP - 739

EP - 750

JO - Neurochemistry International

JF - Neurochemistry International

SN - 0197-0186

IS - 7

ER -